Pathogenesis of Hyperhomocysteinemia-New Insights

Area of Science:

• Biochemistry
• Vascular Biology
• Thrombosis Research

Background:

• Hyperhomocysteinemia is a significant risk factor for atherosclerotic vascular disease and thromboembolism.
• The precise molecular mechanisms underlying homocysteine's prothrombotic effects remain incompletely understood.
• Previous in vitro studies often used non-physiological homocysteine concentrations, questioning their clinical relevance.

Purpose of the Study:

• To investigate the molecular mechanism by which homocysteine contributes to thrombosis.
• To determine if homocysteine induces tissue factor expression in monocytes at physiologically relevant concentrations.
• To elucidate the intracellular pathways involved in homocysteine-mediated monocyte activation.

Main Methods:

• Incubation of monocytes with homocysteine at physiologically relevant concentrations.
• Assessment of tissue factor expression on monocytes.
• Measurement of intracellular S-adenosylhomocysteine levels.
• Analysis of methyl transferase activity.

Main Results:

• Homocysteine, at physiologically relevant concentrations, specifically induces tissue factor expression by monocytes.
• This effect is independent of non-specific oxidant reactivity.
• Increased intracellular S-adenosylhomocysteine mediates tissue factor expression by inhibiting methyl transferases.

Conclusions:

• Homocysteine induces tissue factor expression in monocytes via intracellular perturbations, specifically increased S-adenosylhomocysteine.
• This mechanism provides a plausible explanation for homocysteine's role in promoting thrombosis.
• Targeting these intracellular pathways may offer novel therapeutic strategies for hyperhomocysteinemia-related vascular events.